Search

Search Results

• Internal Medicine Ward with Hematological Skills for the Treatment of Complications Suffered by Hematological Patients on Therapy: Experience of Villa Betania Hospital inRome

  alessandro andriani, Laura Marchetti, Fabio Rossi, Silvia Raja, Maria Antonietta Perretti, Umberto Recine

  e2024030

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.030

  576

  PDF: 1001

  HTML: 80

• THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis

  ANTONIO LEONE, SILVIA MACAGNINO, GIULIA D'AMBRA, DANIELE PERLA

  e2021056

  2021-08-28

  https://doi.org/10.4084/MJHID.2021.056

  1411

  PDF: 513

  HTML: 660

• SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASE

  Nicola Semeraro, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

  e2010024

  2010-08-06

  https://doi.org/10.4084/mjhid.2010.024

  3182

  PDF: 1601

  HTML: 4371

• CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

  Ahmet Yigitbasi, Elif Gulsum Umit, Ufuk Demirci, Guray Aygun, Nese Varli, Elif Aksoy, Fehmi Hindilerden, Emine Gulturk, Eren Arslan Davulcu, Ahmet Muzaffer Demir

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.027

  591

  PDF: 320

  HTML: 60

• CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab

  r. Salam Al-Kindi, Isra Al-Busaidi, Anil Pathare

  e2024046

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.046

  1260

  PDF: 1087

  HTML: 93

• HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19

  Stefano Botti, Nicola Serra, Fausto Castagnetti, Sabina Chiaretti, Nicola Mordini, Gianpaolo Gargiulo, Laura Orlando

  e2021011

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.011

  1524

  PDF: 548

  HTML: 213

• IMMUNOLOGY OF TUBERCULOSIS

  Federica Bozzano, Francesco Marras, Andrea De Maria

  e2014027

  2014-04-07

  https://doi.org/10.4084/mjhid.2014.027

  5119

  PDF: 1958

  HTML: 7249

  Untitled: 185

• EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES

  Kjeld Schmiegelow

  e2011020

  2011-05-16

  https://doi.org/10.4084/mjhid.2011.020

  2131

  PDF: 770

  HTML: 1605

  Figure 1: 162

  Table 1: 186

• Acquired CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma

  Martina Canichella, Stefano Fratoni, Carla Mazzone, alice di rocco, elisabetta abruzzese

  e2026014

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.014

  650

  PDF: 592

  Html: 118

• Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis

  Alessandro Laganà, Giovanni Manfredi Assanto, Mauro Passucci, Cristina Santoro, Antonio Chistolini

  e2024047

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.047

  1108

  PDF: 956

  HTML: 73

• THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM

  May Basood, Howard S. Oster, Moshe Mittelman

  e2018046

  2018-07-01

  https://doi.org/10.4084/mjhid.2018.046

  2965

  PDF: 1333

  HTML: 513

• The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY

  Sarah Liptrott, Mairéad NíChonghaile, Liz O'Connell, Erik Aerts

  e2023033

  2023-04-28

  https://doi.org/10.4084/MJHID.2023.033

  1662

  Suppl. Files: 828

  HTML: 403

  PDF: 705

• GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES

  Laura Breda, Roberto Gambari, Stefano Rivella

  e2009008

  2009-11-16

  1223

  PDF: 411

  HTML: 2867

• Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma

  Vincenzo Sammartano, Sara Ciofini, Beatrice Esposito Vangone, Chiara Carrara, Monica Bocchia, Alessandro Gozzetti

  e2025051

  2025-06-29

  https://doi.org/10.4084/MJHID.2025.051

  675

  PDF: 535

  HTML: 19

• TYROSINE KINASE INHIBITORS AND PREGNANCY

  Elisabetta Abruzzese, Malgorzata Monika Trawinska, Paolo De Fabritiis, Alessio Pio Perrotti

  e2014028

  2014-04-07

  https://doi.org/10.4084/mjhid.2014.028

  3429

  PDF: 1579

  HTML: 2662

• CHANGES OF VON WILLEBRAND FACTOR DURING PREGNANCY IN WOMEN WITHOUT AND WITH VON WILLEBRAND DISEASE

  Giancarlo Castaman

  e2013052

  2013-07-16

  https://doi.org/10.4084/mjhid.2013.052

  2978

  PDF: 1010

  HTML: 8523

• Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era

  Serena Vita, Emanuela Giacobini, Patrizia De Marco, Martina Rueca, Cesare Ernesto Maria Gruber, Alessia Beccacece, Laura Scorzolini, Valentina Mazzotta, Carmen Pinnetti, Priscilla Caputi, Daniele Focosi, Enrico Girardi, Andrea Antinori, Fabrizio Maggi, Alessandra D'Abramo, Emanuele Nicastri, Spallanzani COVID-19 case Investigation Team

  e2024043

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.043

  1202

  PDF: 901

  HTML: 83

• THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS

  FASOLA ATINUKE

  e2022001

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.001

  2162

  PDF: 924

  HTML: 57

• APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS

  Rita Wilson Dib, Ray Hachem, Anne-Marie P Chaftari, Issam I Raad

  e2018028

  2018-05-01

  https://doi.org/10.4084/mjhid.2018.028

  2706

  PDF: 886

  HTML: 342

  Preferred Reviewers: 189

• Prevention of Early Death in Very Elderly Acute Promyelocytic Leukemia Patients Using Lower Induction Doses of All-trans Retinoic Acid

  Mark Dalgetty, Sruthi Dontu, Chandini Kannan, Amany Keruakous, Locke Bryan, Vamsi Kota, Anand Jillella

  e2025066

  2025-08-31

  https://doi.org/10.4084/MJHID.2025.066

  840

  PDF: 565

  Html: 104

• LEVOFLOXACIN PROPHYLAXIS VERSUS NO PROPHYLAXIS IN ACUTE MYELOID LEUKEMIA DURING POST-INDUCTION APLASIA: A SINGLE CENTER STUDY

  Irene Urbino, Chiara Frairia, Alessandro Busca, Silvia Corcione, Stefano D'Ardia, Chiara Maria Dellacasa, Valentina Giai, Carolina Secreto, Roberto Freilone, Francesco Giuseppe De Rosa, Semra Aydin, Giovannino Ciccone, Rosalba Rosato, Marco Cerrano, Ernesta Audisio

  e2023022

  2023-02-28

  https://doi.org/10.4084/MJHID.2023.022

  1435

  PDF: 1025

  HTML: 385

• Isavuconazole therapy of disseminated and encephalic Saprochaete capitata infection in an acute myeloid leukemia patient treated with midostaurin.

  Salvatore Perrone, Chiara Lisi, Elettra Ortu La Barbera, Cristina Luise, Miriam Lichtner, Corrado Girmenia, Giuseppe Cimino

  e2020026

  2020-04-27

  https://doi.org/10.4084/mjhid.2020.026

  1336

  PDF: 770

  HTML: 297

• SUCCESSFUL LONG TERM ERADICATION OF FACTOR VIII INHIBITOR IN PATIENTS WITH ACQUIRED HAEMOPHILIA A IN SAUDI ARABIA

  Galila F Zaher, Soheir S Adam

  e2012021

  2012-04-02

  https://doi.org/10.4084/mjhid.2012.021

  1245

  PDF: 873

  HTML: 3575

• Mantle cell lymphoma relapsing at the lymphedematous arm.

  Giuseppina Massini, Stefan Hohaus, Francesco D'Alo', Valentina Bozzoli, Barbara Vannata, Luigi Maria Larocca, Luciana Teofili

  e2013016

  2013-02-16

  https://doi.org/10.4084/mjhid.2013.016

  1648

  PDF: 672

  HTML: 3780

• Adjuvant corticosteroid therapy in hepatosplenic candidiasis-related IRIS

  Cengiz Bayram, Ali Fettah, Nese Yarali, Abdurrahman Kara, Fatih Mehmet Azik, Betül Tavil, Bahattin Tunc

  e2012018

  2012-03-13

  https://doi.org/10.4084/mjhid.2012.018

  1564

  PDF: 770

  HTML: 1189

• HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA: A TALE OF ENDLESS REVOLUTION

  Francesco Lo-Coco, Laura Cicconi

  e2011067

  2011-12-21

  https://doi.org/10.4084/mjhid.2011.067

  3053

  PDF: 1086

  HTML: 1718

• CLINICAL USEFULNESS OF BROCHOALVEOLAR LAVAGE IN THE MANAGEMENT OF PULMONARY INFILTRATES IN ADULTS WITH HAEMATOLOGICAL MALIGNANCIES AND STEM CELL TRANSPLANTATION

  Laura Jorge, Diego Torres, Agustín Languasco, Pablo Rodriguez, Pablo Bonvehí, Elena Temporiti, Silvia Relloso, Cristina Videla, Fabián Herrera

  e2020025

  2020-05-01

  https://doi.org/10.4084/mjhid.2020.025

  8020

  PDF: 733

  HTML: 200

• AGE AT DIAGNOSIS OF SICKLE CELL ANAEMIA IN LAGOS, NIGERIA

  Femi Akodu, I N Diaku-Akinwumi, O F Njokanma

  e2013001

  2013-01-02

  https://doi.org/10.4084/mjhid.2013.001

  1921

  PDF: 865

  HTML: 1848

• IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA

  Ugo Testa, Prof. Leone, Dr. Elvira Pelosi, Dr. Germana Castelli, Prof, Valerio De Stefano

  e2024044

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.044

  2486

  PDF: 1093

  HTML: 123

• OUTCOMES OF OVERT AND NON-OVERT DISSEMINATED INTRAVASCULAR COAGULATION USING THE ISTH DIC SCORING SYSTEM IN CHILDREN: A SINGLE-CENTER STUDY

  Jassada Buaboonnam, Chonthida Wnagkittikal, Nattee Narkbunnam, Nassawee Vathana, Chayamon Takpradit, Kamon Phuakpet, Phakatip Sinlapamongkolkul, Kleebsabai Sanpakit, Khemajira Karaketklang, Bunchoo Pongtanakul

  e2023004

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.004

  1133

  PDF: 1075

  HTML: 590

• IMMUNOLOGICAL EVOLUTION OF A COHORT OF HIV-2 INFECTED PATIENTS: PECULIARITIES OF AN UNDERESTIMATED INFECTION HIV-2 INFECTED PATIENTS PECULIARITIES

  Emanuele Focà, Benedetta Fumarola

  e2022016

  2022-02-27

  https://doi.org/10.4084/MJHID.2022.016

  932

  PDF: 584

  HTML: 215

• Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments

  NICOLA SGHERZA, Anna Mestice, Angela Maria Vittoria Larocca, Pellegrino Musto

  e2024022

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.022

  684

  PDF: 1107

  HTML: 77

• FINE MAPPING OF GLUCOSE 6 PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY IN RURAL AREA OF SOUTH WEST ODISHA USING THE CLINICAL, HEMATOLOGICAL AND MOLECULAR APPROACH

  Ravindra Kumar, MPSS Singh, Soumendu Mahapatra, Sonam Chourasia, Malay Kumar Tripathi, John Oommen, Praveen Kumar Bharti, Rajasubramaniam Shanmugam

  e2020015

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.015

  1677

  PDF: 982

  HTML: 515

• Late-onset hepatic veno-occlusive disease after allografting: report of two cases with atypical clinical features successfully treated with defibrotide.

  Alessia Castellino, Stefano Guidi, Chiara Dellacasa, Antonella Gozzini, Irene Donnini, Chiara Nozzoli, Sara Manetta, Semra Aydin, Luisa Giaccone, Moreno Festuccia, Lucia Brunello, Enrico Maffini, Benedetto Bruno, Ezio David, Alessandro Busca

  e2018001

  2018-01-01

  https://doi.org/10.4084/mjhid.2018.001

  4012

  PDF: 965

  HTML: 976

• Evaluation of Hepatitis B and C Reactivation in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

  Nathalia Sena de Oliveira Silva, Gislaine Duarte, Samuel de Souza Medina, Guilherme Brasil Duffles Amarante, Carmino Antonio de Souza, Katia Borgia Barbosa Pagnano

  e2026001

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.001

  587

  PDF: 371

  Html: 68

• IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy

  İbrahim Halil Açar, Sebnem Izmir Güner , Muzeyyen Aslaner Ak, Mesut Gocer, Erman Ozturk , Figen Atalay, Gulden Sincan , Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Emine Gulturk , Nazli Demir, Ali Dogan, Yildiz Ipek, Birol Guvenc

  e2022074

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.074

  1354

  PDF: 721

  HTML: 191

• MECHANISM OF SARS-COV-2 INVASION INTO THE LIVER AND HEPATIC INJURY IN PATIENTS WITH COVID-19

  XiaoTian Zhang, Yanhui Yu, Chao Zhang, Lijuan Zhao, Hongrui Wang, Guoqing Wang, Ming Yang

  e2022003

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.003

  1795

  PDF: 1025

  HTML: 275

• IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?

  Benedetto Maurizio Celesia, Dr., Andrea Marino, Dr., Rosa Fontana del Vecchio, Dr., Roberto Bruno, Dr., Filippo Palermo, Professor, Maria Gussio, Dr., Giuseppe Nunnari, Professor, Bruno Cacopardo, Professor

  e2019063

  2019-10-30

  https://doi.org/10.4084/mjhid.2019.063

  1182

  PDF: 711

  HTML: 203

• THE START-UP OF THE FIRST HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER IN THE IRAQI KURDISTAN: A CAPACITY-BUILDING COOPERATIVE PROJECT BY THE HIWA CANCER HOSPITAL, SULAYMANIYAH, AND THE ITALIAN AGENCY FOR DEVELOPMENT COOPERATION

  Ignazio Majolino

  e2017031

  2017-04-15

  https://doi.org/10.4084/mjhid.2017.031

  2185

  PDF: 968

  HTML: 2066

• Acquired Hemophilia A successfully treated with rituximab

  Giovanni D'Arena, Elvira Grandone, Matteo Nicola Dario Di Minno, Pellegrino Musto, Giovanni Di Minno

  e2015024

  2015-02-17

  https://doi.org/10.4084/mjhid.2015.024

  1849

  PDF: 1094

  HTML: 1443

  Figure 1: 151

• COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA

  Sanjeev Kumar Sharma, Dharma Choudhary, Nitin Gupta, Mayank Dhamija, Vipin Khandelwal, Gaurav Kharya, Anil Handoo, Rasika Setia, Arpita Arora

  e2014046

  2014-06-29

  https://doi.org/10.4084/mjhid.2014.046

  2570

  PDF: 945

  HTML: 4684

• Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET

  Alessandro Gozzetti, Vania Rossi, Alfonso Cerase, Giulia Papini, Marzia Defina, Monica Bocchia

  e2012041

  2012-06-19

  https://doi.org/10.4084/mjhid.2012.041

  1065

  PDF: 629

  HTML: 558

• Progression from Carbapenem-Resistant Enterobacterales Colonization to Bloodstream Infection in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Cohort Study

  Candida Diaz, Daniela Rodriguez-Feria, Javier Garzon, Oscar Muñoz

  e2026041

  2026-04-30

  https://doi.org/10.4084/MJHID.2026.041

  0

  PDF: 0

  HTML: 0

• SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib

  Matteo Molica

  e2024079

  2024-10-31

  https://doi.org/10.4084/MJHID.2024.079

  899

  PDF: 488

  HTML: 171

• A case of central venous catheter-related Candida parapsilosis fungemia evolved to disseminated infection in a neutropenic patient with blast crisis of chronic myeloid leukemia.

  Elena Amabile, Matteo Totaro, Luca Cappelli, Clara Minotti, Alessandra Micozzi

  e2024013

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.013

  869

  PDF: 1144

  HTML: 137

• CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease

  Vincenzo De Sanctis

  e2020032

  2020-04-27

  https://doi.org/10.4084/mjhid.2020.032

  2066

  PDF: 1379

  HTML: 682

• Parvovirus B19-triggered acute hemolytic anemia and thrombocytopenia in a child with Evans syndrome

  ELPIS MANTADAKIS

  e2018018

  2018-03-01

  https://doi.org/10.4084/mjhid.2018.018

  3417

  PDF: 947

  HTML: 388

  Table 1.: 208

• ASSESSMENT OF OBESITY AND HEPATIC LATE ADVERSE EFFECTS IN THE EGYPTIAN SURVIVORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER STUDY

  Farida El-Rashedy, Mahmoud Ahmed El-Hawy, Sally El Hefnawy, Mona Mohammed

  e2017026

  2017-04-15

  https://doi.org/10.4084/mjhid.2017.026

  2431

  PDF: 856

  HTML: 1274

  Untitled: 198

• BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA

  Alzbeta Zavrelova, Jakub Radocha, Pavla Paterova, Pavel Zak, Benjamin Visek, Martin Sima

  e2023001

  2022-12-31

  https://doi.org/10.4084/MJHID.2023.001

  1142

  PDF: 1066

  HTML: 417

• ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS

  chiara mozzini, giancarlo pesce, alder casadei, domenico girelli, maurizio soresi

  e2019066

  2019-10-30

  https://doi.org/10.4084/mjhid.2019.066

  1310

  PDF: 854

  HTML: 1758